Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy

Sulggi Lee, Helen Byakwaga, Yap Boum, Tricia H. Burdo, Kenneth C. Williams, Michael M. Lederman, Yong Huang, Russell P. Tracy, Huyen Cao, Jessica E. Haberer, Annet Kembabazi, David Bangsberg, Jeffrey N. Martin, Peter W. Hunt

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The plasma kynurenine/tryptophan (KT) ratio, a marker of adaptive immune defects, strongly predicts mortality during treated human immunodeficiency virus (HIV) disease in Ugandans as compared to US-based populations. Here, the KT ratio and T-cell and plasma biomarkers of immune activation were measured among 535 HIV-infected Ugandans prior to ART initiation and at month 6 of viral suppression. The month 6 KT ratio (adjusted hazard ratio [aHR], 2.74), soluble CD14 level (aHR, 2.32), interleukin 6 level (aHR, 2.34), and D-dimer level (aHR, 1.95) were associated with mortality occurring ≥6 months after ART initiation. The KT ratio remained significantly predictive of mortality even after adjustment for the additional biomarkers, suggesting an independent contribution to clinical outcomes in resource-limited settings.

Original languageEnglish (US)
Pages (from-to)1270-1274
Number of pages5
JournalThe Journal of infectious diseases
Volume215
Issue number8
DOIs
StatePublished - Apr 15 2017

Fingerprint

Kynurenine
Tryptophan
HIV
Mortality
Biomarkers
Virus Diseases
Therapeutics
Interleukin-6
T-Lymphocytes
Population

Keywords

  • Africa.
  • antiretroviral therapy
  • D-dimer
  • HIV
  • IL-6
  • kynurenine
  • mortality
  • sCD14
  • tryptophan

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Lee, S., Byakwaga, H., Boum, Y., Burdo, T. H., Williams, K. C., Lederman, M. M., ... Hunt, P. W. (2017). Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy. The Journal of infectious diseases, 215(8), 1270-1274. https://doi.org/10.1093/infdis/jix113

Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy. / Lee, Sulggi; Byakwaga, Helen; Boum, Yap; Burdo, Tricia H.; Williams, Kenneth C.; Lederman, Michael M.; Huang, Yong; Tracy, Russell P.; Cao, Huyen; Haberer, Jessica E.; Kembabazi, Annet; Bangsberg, David; Martin, Jeffrey N.; Hunt, Peter W.

In: The Journal of infectious diseases, Vol. 215, No. 8, 15.04.2017, p. 1270-1274.

Research output: Contribution to journalArticle

Lee, S, Byakwaga, H, Boum, Y, Burdo, TH, Williams, KC, Lederman, MM, Huang, Y, Tracy, RP, Cao, H, Haberer, JE, Kembabazi, A, Bangsberg, D, Martin, JN & Hunt, PW 2017, 'Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy', The Journal of infectious diseases, vol. 215, no. 8, pp. 1270-1274. https://doi.org/10.1093/infdis/jix113
Lee, Sulggi ; Byakwaga, Helen ; Boum, Yap ; Burdo, Tricia H. ; Williams, Kenneth C. ; Lederman, Michael M. ; Huang, Yong ; Tracy, Russell P. ; Cao, Huyen ; Haberer, Jessica E. ; Kembabazi, Annet ; Bangsberg, David ; Martin, Jeffrey N. ; Hunt, Peter W. / Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy. In: The Journal of infectious diseases. 2017 ; Vol. 215, No. 8. pp. 1270-1274.
@article{90bd3deb4158451593743ea24f352284,
title = "Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy",
abstract = "The plasma kynurenine/tryptophan (KT) ratio, a marker of adaptive immune defects, strongly predicts mortality during treated human immunodeficiency virus (HIV) disease in Ugandans as compared to US-based populations. Here, the KT ratio and T-cell and plasma biomarkers of immune activation were measured among 535 HIV-infected Ugandans prior to ART initiation and at month 6 of viral suppression. The month 6 KT ratio (adjusted hazard ratio [aHR], 2.74), soluble CD14 level (aHR, 2.32), interleukin 6 level (aHR, 2.34), and D-dimer level (aHR, 1.95) were associated with mortality occurring ≥6 months after ART initiation. The KT ratio remained significantly predictive of mortality even after adjustment for the additional biomarkers, suggesting an independent contribution to clinical outcomes in resource-limited settings.",
keywords = "Africa., antiretroviral therapy, D-dimer, HIV, IL-6, kynurenine, mortality, sCD14, tryptophan",
author = "Sulggi Lee and Helen Byakwaga and Yap Boum and Burdo, {Tricia H.} and Williams, {Kenneth C.} and Lederman, {Michael M.} and Yong Huang and Tracy, {Russell P.} and Huyen Cao and Haberer, {Jessica E.} and Annet Kembabazi and David Bangsberg and Martin, {Jeffrey N.} and Hunt, {Peter W.}",
year = "2017",
month = "4",
day = "15",
doi = "10.1093/infdis/jix113",
language = "English (US)",
volume = "215",
pages = "1270--1274",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy

AU - Lee, Sulggi

AU - Byakwaga, Helen

AU - Boum, Yap

AU - Burdo, Tricia H.

AU - Williams, Kenneth C.

AU - Lederman, Michael M.

AU - Huang, Yong

AU - Tracy, Russell P.

AU - Cao, Huyen

AU - Haberer, Jessica E.

AU - Kembabazi, Annet

AU - Bangsberg, David

AU - Martin, Jeffrey N.

AU - Hunt, Peter W.

PY - 2017/4/15

Y1 - 2017/4/15

N2 - The plasma kynurenine/tryptophan (KT) ratio, a marker of adaptive immune defects, strongly predicts mortality during treated human immunodeficiency virus (HIV) disease in Ugandans as compared to US-based populations. Here, the KT ratio and T-cell and plasma biomarkers of immune activation were measured among 535 HIV-infected Ugandans prior to ART initiation and at month 6 of viral suppression. The month 6 KT ratio (adjusted hazard ratio [aHR], 2.74), soluble CD14 level (aHR, 2.32), interleukin 6 level (aHR, 2.34), and D-dimer level (aHR, 1.95) were associated with mortality occurring ≥6 months after ART initiation. The KT ratio remained significantly predictive of mortality even after adjustment for the additional biomarkers, suggesting an independent contribution to clinical outcomes in resource-limited settings.

AB - The plasma kynurenine/tryptophan (KT) ratio, a marker of adaptive immune defects, strongly predicts mortality during treated human immunodeficiency virus (HIV) disease in Ugandans as compared to US-based populations. Here, the KT ratio and T-cell and plasma biomarkers of immune activation were measured among 535 HIV-infected Ugandans prior to ART initiation and at month 6 of viral suppression. The month 6 KT ratio (adjusted hazard ratio [aHR], 2.74), soluble CD14 level (aHR, 2.32), interleukin 6 level (aHR, 2.34), and D-dimer level (aHR, 1.95) were associated with mortality occurring ≥6 months after ART initiation. The KT ratio remained significantly predictive of mortality even after adjustment for the additional biomarkers, suggesting an independent contribution to clinical outcomes in resource-limited settings.

KW - Africa.

KW - antiretroviral therapy

KW - D-dimer

KW - HIV

KW - IL-6

KW - kynurenine

KW - mortality

KW - sCD14

KW - tryptophan

UR - http://www.scopus.com/inward/record.url?scp=85026720827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026720827&partnerID=8YFLogxK

U2 - 10.1093/infdis/jix113

DO - 10.1093/infdis/jix113

M3 - Article

VL - 215

SP - 1270

EP - 1274

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 8

ER -